99% Savings - Buy Just @1 Rs X
Rozustat F Tablet, a prescription drug, is manufactured in various forms such as Tablet. Rozustat F Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Rozustat F Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The most common side effects of Rozustat F Tablet are Nausea or vomiting, Headache, Constipation. Besides the aforementioned side effects, there are other adverse effects of Rozustat F Tablet as well, which are listed below. Usually, these side effects of Rozustat F Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Rozustat F Tablet's effect during pregnancy is Moderate and Moderate while nursing. It is important to know if Rozustat F Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Rozustat F Tablet related warnings section.
Rozustat F Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Rozustat F Tablet in conditions like Diabetes.
Besides this, Rozustat F Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Rozustat F Tablet is not safe while driving, and is not addiction.
Rozustat F Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Rozustat F Tablet safe for pregnant women?
Rozustat F may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Rozustat F again without your doctor's advice.
Is the use of Rozustat F Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Rozustat F. If you see any side effects, stop taking Rozustat F immediately and talk to your doctor. Take Rozustat F again, only after your doctor's advice.
What is the effect of Rozustat F Tablet on the Kidneys?
Very few cases of side effects of Rozustat F on kidney have been reported.
What is the effect of Rozustat F Tablet on the Liver?
Rozustat F is rarely harmful for the liver.
What is the effect of Rozustat F Tablet on the Heart?
You may experience side effects on your heart after taking Rozustat F. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Rozustat F Tablet unless your doctor advises you to do so -
Is this Rozustat F Tablet habit forming or addictive?
Rozustat F Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Rozustat F Tablet can make you feel drowsy.
Is it safe?
Rozustat F Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Rozustat F Tablet is not used to treat mental disorders.
Interaction between Food and Rozustat F Tablet
There isn't any research available on the side effects of taking Rozustat F Tablet with food.
Interaction between Alcohol and Rozustat F Tablet
Due to lack of research, there is no information about the side effects of taking Rozustat F Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650